We are live on ! Find out more
CVV

Curative Ventures V Portfolio holdings

AUM $15.6M
1-Year Est. Return 52.53%
This Fund
S&P 500
This Quarter Est. Return
-4.31%
1 Year Est. Return
-52.53%
3 Year Est. Return
-37.67%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$650M
AUM Growth
–
Cap. Flow
+$733M
Cap. Flow %
112.79%
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
TIL icon
Instil Bio
TIL
+$733M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TIL icon
1
Instil Bio
TIL
$49M
$650M 100%
+1,899,004
New +$733M

Similar funds

SRA
Summit Rock Advisors New York $16M AUM
BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
GMP
Great Mountain Partners New Haven, Connecticut $15.1M AUM 92.9% 1-Year Est. Return
SR
Swiss Re Zurich, Switzerland $16.4M AUM
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
PA
PPM America Chicago, Illinois $16.6M AUM 31.99% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
ONGA
O'Neil Global Advisors Los Angeles, California $14.4M AUM 220.73% 1-Year Est. Return

Curative Ventures V's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for Curative Ventures V, which disclosed 1 position worth $650M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Instil Bio: 1,899,004 shares worth $650M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Curative Ventures V's largest Q4 2021 buy was Instil Bio: 1,899,004 shares worth $650M.
  • Curative Ventures V's ten largest holdings make up 100% of its $650M portfolio in Q4 2021.
  • Curative Ventures V disclosed 1 position in Q4 2021, its first 13F filing on record.

Based on Curative Ventures V's 13F filing for Q4 2021, filed 14 Feb 2022.